Literature DB >> 29249438

Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis.

Dae-Won Kim1, Sung-Ho Her2, Youngkeun Ahn3, Dong Il Shin4, Seung Hwan Han5, Dong-Soo Kim6, Dong-Ju Choi7, Hyuck Moon Kwon8, Hyeon-Cheol Gwon9, Sang-Ho Jo10, Seung-Woon Rha11, Sang Hong Baek12.   

Abstract

BACKGROUND: This study aimed to evaluate clinical implications of single vessel coronary spasm provoked by intracoronary ergonovine provocation test in Korean population.
METHOD: A total of 1248 patients who presented with single vessel coronary artery spasm induced by intracoronary ergonovine provocation test, excluding 1712 with negative spasms, multiple and mixed coronary artery spasms and missing data among 2960 patients in the VA-KOREA (Vasospastic Angina in Korea) registry, were classified into diffuse (n=705) and focal (n=543) groups.
RESULTS: The 24-month incidences of a composite primary endpoints (cardiac death, new-onset arrhythmia, and acute coronary syndrome) were determined. Over a median follow-up of 30months, the composite primary end point occurred more frequently in the focal type patients than in the diffuse type patients (primary endpoint: adjusted hazard ratio [aHR], 1.658; 95% confidence interval [CI] 1.272 to 2.162, P<0.001). Especially, unstable angina in ACS components played a major role in this effect (hazard ratio [HR], 2.365; 95% confidence interval [CI] 1.100 to 5.087, P=0.028).
CONCLUSION: Focal type of single vessel coronary artery spasm in vasospastic angina (VSA) patients is found to be associated with worse clinical outcomes. It is thought that the effect is stemmed from unstable angina among ACS rather than the other components of primary endpoint. Therefore, focal type of single vessel coronary artery spasm in patients with VSA should be more carefully assessed and managed with appropriate medication.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Focal spasm; Single vessel spasm; Vasospastic angina

Mesh:

Substances:

Year:  2018        PMID: 29249438     DOI: 10.1016/j.ijcard.2017.08.052

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

Review 1.  Non-invasive diagnosis of vasospastic angina.

Authors:  Vincent Ngo; Anahita Tavoosi; Alexandre Natalis; Francois Harel; E Marc Jolicoeur; Robert S B Beanlands; Matthieu Pelletier-Galarneau
Journal:  J Nucl Cardiol       Date:  2022-03-23       Impact factor: 5.952

2.  Admission serum potassium levels and prognosis of vasospastic angina.

Authors:  Won-Woo Seo; Sang-Ho Jo; Sung Eun Kim; Hyun-Jin Kim; Seung Hwan Han; Kwan Yong Lee; Sung Ho Her; Min-Ho Lee; Seong-Sik Cho; Hack-Lyoung Kim; Sang Hong Baek
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

Review 3.  Coronary Vasospastic Angina: A Review of the Pathogenesis, Diagnosis, and Management.

Authors:  Rajan Rehan; James Weaver; Andy Yong
Journal:  Life (Basel)       Date:  2022-07-27

4.  Nitrates vs. Other Types of Vasodilators and Clinical Outcomes in Patients with Vasospastic Angina: A Propensity Score-Matched Analysis.

Authors:  Hyun-Jin Kim; Sang-Ho Jo; Min-Ho Lee; Won-Woo Seo; Hack-Lyoung Kim; Kwan Yong Lee; Tae-Hyun Yang; Sung-Ho Her; Byoung-Kwon Lee; Keun-Ho Park; Youngkeun Ahn; Seung-Woon Rha; Hyeon-Cheol Gwon; Dong-Ju Choi; Sang Hong Baek
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.